September is World Alzheimer’s Month, an international campaign to challenge the stigma that surrounds dementia, a disease that affects almost 150,000 people in Switzerland. It is the third most frequent cause of death in the country, costing over CHF 7 billion a year – and as many as 400,000 predominantly elderly Swiss people may live...
Read moreI have not forgotten the Chinese taxi driver who wanted to sell me a Rolex for $100 in Singapore a while back. Nor have I forgotten his absolute fury when I laughed and told him that if I wanted to buy a fake Rolex, I could have done it in Bangkok for $5. Since then,...
Read moreDelivered by Cyntia Genolet, Manager, Regulatory and Health Policy 30th August, Victoria Falls, Republic of Zimbabwe – Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across the world, including two in Africa. Today’s meeting and the organization...
Read moreDelivered by Cyntia Genolet, Manager, Regulatory and Health Policy 30th August, Victoria Falls, Republic of Zimbabwe – IFPMA commends the EYE strategy, which brings renewed vision and energy to controlling yellow fever across the world by reducing the risk posed by an urban foothold of the disease. We were glad to be a part of...
Read moreFair pricing activists applauded the news earlier this month that the FDA approved another drug to cure hepatitis C. That this new medicine is cheaper and treats people quicker than the existing hepatitis C drugs goes to show how fast healthy competition can change the outlook on health spending. Not long ago, health economists were promoting a...
Read moreWe are used to social media exploding and controversy over statements made by President Donald Trump. But over the past month, a shockwave of anger and charges of European arrogance and racism have been levelled at France’s new, charming, and youthful President. What triggered the social media storm that spread around the world was President...
Read moreThis position paper reiterates the global industry position on GMP convergence (June 2017 position paper and addresses the ICDRA WHO recommendations to industry with regard to the sharing of inspections information amongst regulators and procurement agencies under the Reliance approach.
Read moreGeneva, 6 June 2017|Today, the WHO issued its 20th Essential Medicines List (EML) This List serves as a guide for countries and procurement agencies in making their own decisions about the medicines in their own formularies. IFPMA Director General Thomas Cueni gave this statement: “In this year’s List, and from what we can notably see,...
Read moreThe most indisputable of all facts on global health is that we’re living longer and healthier lives than ever, and in an era of continuous health improvement. What were once considered life-threatening diseases are now manageable conditions, and not just for patients, but for our health systems also. Where Hepatitis C, for example, would have...
Read more